John M. Falatko

John Falatko practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

John Falatko's NPI, 1093001240, was assigned on June 27, 2011. John Falatko graduated from Oklahoma State University College of Osteopathic Medicine in 2011. John Falatko holds Indiana license 02005132A.

John Falatko's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

John Falatko's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. John Falatko is also affiliated with Dupont Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links John Falatko to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Falatko practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is John Falatko's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has John Falatko's licenses on file in 3 states: Indiana, Alabama and Michigan.

CMS data shows 840 Medicare services from John Falatko across 7 procedure codes in 2024, for 287 Medicare patients. Medicare paid $45,761 for them. Every service was in an office.

CMS counts 287 Medicare patients who saw John Falatko in 2024. The largest group is 65 to 74, with 141 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts John Falatko's median patient age at 73, with 45% women.

In 2024, John Falatko wrote 9,123 Medicare Part D claims for 739 patients. 86% of them were for generic drugs. CMS names the drug for 8,429 of them, across 136 drugs with 11 or more claims each, at $859,551 in total drug cost. In 2023, CMS named 8,850 claims across 153 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for John Falatko for performance year 2024, reported as part of a group. John Falatko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists John Falatko as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to John Falatko, published from 2014 to 2018. John Falatko's most frequent co-authors are Noora Kazanji, DO, Alexandra I. Halalau and Michael E. Maddens.

CMS Open Payments shows 53 general payments to John Falatko from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $199.

John Falatko graduated from Oklahoma State University College of Osteopathic Medicine in 2011.